These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25760096)

  • 1. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
    Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
    Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathway.
    Zhang W; Zheng X; Meng T; You H; Dong Y; Xing J; Chen S
    J Drug Target; 2017 Mar; 25(3):255-263. PubMed ID: 27718638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2.
    Cai J; Chen S; Zhang W; Hu S; Lu J; Xing J; Dong Y
    Phytomedicine; 2014 Jun; 21(7):984-91. PubMed ID: 24680370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells.
    Li Y; Zhai Z; Li H; Wang X; Huang Y; Su X
    Chem Biol Interact; 2019 May; 305():98-104. PubMed ID: 30929998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
    Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
    Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway.
    Cai J; Chen S; Zhang W; Zheng X; Hu S; Pang C; Lu J; Xing J; Dong Y
    Phytomedicine; 2014 Oct; 21(12):1725-32. PubMed ID: 25442283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway.
    Li G; Xu D; Sun J; Zhao S; Zheng D
    Adv Clin Exp Med; 2020 Nov; 29(11):1337-1345. PubMed ID: 33269821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer.
    Chen SY; Zheng XW; Cai JX; Zhang WP; You HS; Xing JF; Dong YL
    Int J Oncol; 2016 Jul; 49(1):294-304. PubMed ID: 27211281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells.
    Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y
    Int J Oncol; 2017 Mar; 50(3):893-902. PubMed ID: 28197640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing PCMT1 enhances the sensitivity of breast cancer cells to paclitaxel through the PI3K/Akt/STMN1 pathway.
    Zhang K; Li JY; Li K
    Chem Biol Drug Des; 2024 Jun; 103(6):e14559. PubMed ID: 38853025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.
    Chen J; Wang W; Wang H; Liu X; Guo X
    Drug Discov Ther; 2014 Feb; 8(1):33-41. PubMed ID: 24647156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-κB signaling pathway in a human breast cancer cell line.
    Lin X; Zhang X; Wang Q; Li J; Zhang P; Zhao M; Li X
    Neoplasma; 2012; 59(3):248-56. PubMed ID: 22329846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway.
    Lei Y; Li HX; Jin WS; Peng WR; Zhang CJ; Bu LJ; Du YY; Ma T; Sun GP
    Int J Radiat Biol; 2013 Dec; 89(12):1079-86. PubMed ID: 23875954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer.
    Liu JJ; Ho JY; Lee HW; Baik MW; Kim O; Choi YJ; Hur SY
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K/Akt in human breast cancer.
    Li Y; Zhao H; Wang Y; Zheng H; Yu W; Chai H; Zhang J; Falck JR; Guo AM; Yue J; Peng R; Yang J
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):37-48. PubMed ID: 23747687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IL-8 inhibits the apoptosis of MCF-7 human breast cancer cells by up-regulating Bcl-2 and down-regulating caspase-3].
    Pang X; Li K; Wei L; Huang Y; Su M; Wang L; Cao H; Chen T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):307-11. PubMed ID: 25744832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.
    Chen S; Dong Q; Hu S; Cai J; Zhang W; Sun J; Wang T; Xie J; He H; Xing J; Lu J; Dong Y
    Mol Biosyst; 2014 Feb; 10(2):294-303. PubMed ID: 24292090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. +TIP EB1 downregulates paclitaxel‑induced proliferation inhibition and apoptosis in breast cancer cells through inhibition of paclitaxel binding on microtubules.
    Thomas GE; Sreeja JS; Gireesh KK; Gupta H; Manna TK
    Int J Oncol; 2015 Jan; 46(1):133-46. PubMed ID: 25310526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
    Velaei K; Samadi N; Soltani S; Barazvan B; Soleimani Rad J
    Breast Cancer; 2017 Jul; 24(4):552-561. PubMed ID: 27878697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.